Physician profile
Sarah M Talbott
NPI 1194124313
$542.31
in general payments reported to CMS, 2019-2025
18 companies · $165 in 2025
The $165 reported for 2025 was less than what a typical Medical provider received nationally (typical 2025 total: $213).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $67.18 · 2022: $57.65 · 2023: $109 · 2024: $144 · 2025: $165.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $417.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $417.48 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Axonics, INC. | $59.88 | 2022-2024 | Axonics |
| Hologic Sales and Service, LLC | $53.85 | 2021-2025 | Novasure, Acessa Provu System |
| Exact Sciences Corporation | $50.92 | 2023-2025 | Cologuard Collection Kit |
| Medtronic, INC. | $49.00 | 2023-2024 | Interstim |
| Coopersurgical, INC. | $45.47 | 2024-2025 | Advincula Delineator Uterine Manipulator, Paragard T 380a |
| Abbott Laboratories | $40.10 | 2023-2024 | Freestyle Libre 3 |
| Pfizer INC. | $36.08 | 2024-2025 | |
| Sage Therapeutics, LLC | $30.20 | 2025 | Zurzuvae |
| Exeltis, USA INC. | $28.68 | 2021-2023 | Slynd |
| Organon LLC | $23.76 | 2021-2022 | |
| Novo Nordisk INC | $20.34 | 2025 | Wegovy |
| Myovant Sciences INC. | $19.76 | 2021 | |
| Abbvie INC. | $15.09 | 2025 | |
| Astellas Pharma US INC | $15.03 | 2024 | Veozah |
| Supernus Pharmaceuticals, INC. | $14.06 | 2025 | Qelbree |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ferring Pharmaceuticals INC. | $13.58 | 2023 | Euflexxa |
| Shield Therapeutics INC | $13.50 | 2023 | Accrufer |
| Cepheid | $13.01 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sarah Talbott listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.